We are live on ! Find out more
PAP

Persistent Asset Partners Portfolio holdings

AUM $268M
1-Year Est. Return 158.98%
This Fund
S&P 500
This Quarter Est. Return
+39.3%
1 Year Est. Return
+158.98%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$223M
AUM Growth
+$77.2M
Cap. Flow
+$48M
Cap. Flow %
21.55%
Top 10 Hldgs %
25.3%
Holding
464
New
223
Increased
67
Reduced
60
Closed
103

Top Buys

Rank Stock Value
1
MOH icon
Molina Healthcare
MOH
+$8.43M
2
ELV icon
Elevance Health
ELV
+$5.15M
3
INTC icon
Intel
INTC
+$4.26M
4
SNDK
Sandisk
SNDK
+$3.61M
5
JNJ icon
Johnson & Johnson
JNJ
+$3.5M

Top Sells

Rank Stock Value
1
IEF icon
iShares 7-10 Year Treasury Bond ETF
IEF
+$4.82M
2
UNH icon
UnitedHealth
UNH
+$3.15M
3
IBIT icon
iShares Bitcoin Trust
IBIT
+$2.87M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$2.84M
5
LH icon
Labcorp
LH
+$2.58M

Sector Composition

Rank Sector Weight
1 Healthcare 52.36%
2 Technology 13.57%
3 Financials 11.27%
4 Communication Services 4.48%
5 Energy 3.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DSGN icon
176
Design Therapeutics
DSGN
$785M
$328K 0.15%
+34,989
New +$274K
JAZZ icon
177
Jazz Pharmaceuticals
JAZZ
$15.5B
$321K 0.14%
1,891
-3,385
-64% -$519K
ITGR icon
178
Integer Holdings
ITGR
$3.24B
$320K 0.14%
+4,075
New +$325K
NPB
179
Northpointe Bancshares
NPB
$650M
$314K 0.14%
18,711
-23,019
-55% -$390K
OCUL icon
180
CALL
Ocular Therapeutix
OCUL
$1.96B
$311K 0.14%
1,459
+1,146
+366% +$13.9K
PFSI icon
181
PennyMac Financial
PFSI
$4.43B
$308K 0.14%
+2,339
New +$298K
CMPX icon
182
Compass Therapeutics
CMPX
$369M
$307K 0.14%
+57,253
New +$264K
ROIV icon
183
Roivant Sciences
ROIV
$24.8B
$306K 0.14%
14,121
-13,546
-49% -$267K
URGN icon
184
UroGen Pharma
URGN
$1.96B
$300K 0.13%
12,806
-7,920
-38% -$172K
U icon
185
Unity
U
$12.7B
$297K 0.13%
+6,734
New +$274K
OCUL icon
186
Ocular Therapeutix
OCUL
$1.96B
$291K 0.13%
+23,984
New +$291K
BNTC icon
187
Benitec Biopharma
BNTC
$439M
$280K 0.13%
+20,753
New +$287K
FBRX icon
188
Forte Biosciences
FBRX
$1B
$277K 0.12%
+10,146
New +$178K
ENTA icon
189
Enanta Pharmaceuticals
ENTA
$400M
$275K 0.12%
+17,466
New +$222K
AVTX icon
190
Avalo Therapeutics
AVTX
$1.02B
$274K 0.12%
+15,087
New +$255K
MAZE
191
Maze Therapeutics
MAZE
$1.56B
$274K 0.12%
+6,605
New +$227K
PRTA icon
192
Prothena Corp
PRTA
$453M
$273K 0.12%
+28,589
New +$291K
OSCR icon
193
Oscar Health
OSCR
$8.77B
$273K 0.12%
+18,976
New +$328K
MLYS icon
194
Mineralys Therapeutics
MLYS
$2.39B
$269K 0.12%
+7,416
New +$297K
TMO icon
195
Thermo Fisher Scientific
TMO
$198B
$267K 0.12%
+460
New +$260K
QURE icon
196
uniQure
QURE
$2.77B
$264K 0.12%
+11,014
New +$425K
RPRX icon
197
Royalty Pharma
RPRX
$25.8B
$255K 0.11%
+6,594
New +$251K
FHTX icon
198
Foghorn Therapeutics
FHTX
$305M
$254K 0.11%
47,108
+35,667
+312% +$162K
RARE icon
199
Ultragenyx Pharmaceutical
RARE
$2.88B
$254K 0.11%
11,029
+8,947
+430% +$294K
INO icon
200
Inovio Pharmaceuticals
INO
$92.1M
$247K 0.11%
+142,164
New +$313K
6 7
8
9 10

Similar funds

VC
VarCov Co Darien, Connecticut $268M AUM
AL
AIP LLC New York $268M AUM 40.4% 1-Year Est. Return
FC
Foursixthree Capital New York $268M AUM 115.24% 1-Year Est. Return
NF
Nvest Financial Portsmouth, New Hampshire $268M AUM 22.87% 1-Year Est. Return
PF
Prosperitas Financial Valencia, California $268M AUM 32.64% 1-Year Est. Return
UI
Untitled Investments New York $269M AUM 11.35% 1-Year Est. Return
SSWM
Strait & Sound Wealth Management San Francisco, California $269M AUM 22.03% 1-Year Est. Return
AC
Applied Capital Little Rock, Arkansas $268M AUM 16.92% 1-Year Est. Return

Persistent Asset Partners's Q4 2025 Portfolio in Review

As of Q4 2025, Persistent Asset Partners held 464 positions worth $223M, up 53% from $145M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Persistent Asset Partners deployed $48M of net new capital in Q4 2025, opening 223 new positions and adding to 67 existing holdings. Its largest new stake was Molina Healthcare: 51,285 shares worth $8.9M.

By sector, the portfolio is most concentrated in Healthcare at 52% of assets, up from 49% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was UnitedHealth, an estimated $3.15M trimmed.

  • Persistent Asset Partners's largest Q4 2025 buy was Molina Healthcare: 51,285 shares worth $8.9M.
  • Persistent Asset Partners added most to Elevance Health in Q4 2025, an estimated $5.15M increase.
  • Persistent Asset Partners's biggest Q4 2025 reduction was UnitedHealth, cutting an estimated $3.15M.
  • Persistent Asset Partners fully exited iShares 7-10 Year Treasury Bond ETF in Q4 2025, selling an estimated $4.82M.
  • Persistent Asset Partners's ten largest holdings make up 25% of its $223M portfolio in Q4 2025.
  • Persistent Asset Partners opened 223 new positions and closed 103 in Q4 2025.
  • Persistent Asset Partners's portfolio value rose 53% quarter-over-quarter to $223M.

Based on Persistent Asset Partners's 13F filing for Q4 2025, filed 17 Feb 2026.